D21 - Interpreting Continuous Glucose Monitoring Data: A Practical Approach

Sunday, August 14, 2022

3:00 PM – 3:45 PM ET

Location: Room 307

CE/CME Hours: 0.75

CE/CME Hours: 0.75
Pharmacology Hours: 0.25
Activity Type: Knowledge-based
UAN: JA4008258-0000-22-198-L01-P
CHES/MCHES: 0.75

We will review a practical approach to interpreting continuous glucose monitoring (CGM) data in both T1D and T2D. Using the DATAA model we will go through systematic approaches to CGM interpretation. The differences in T1D and T2D data interpretation will be reviewed. The DATAA model will then be put into practice using case examples with audience participation.

Primary Presenter(s)

John Daniel Ruck, DNP/FNP, BC-ADM, CDCES

Endocrinology Nurse Practitioner
Joslin Diabetes Center / Harvard Medical School Affiliate
Madison, Alabama

Disclosure: Omnipod (Other Research Support, 401k owns 31 shares of Omnipod (Ticker: PODD))

PDF

Co-Presenter(s)

Lisa Feagan, MSN/Ed, MSN NP-C, BC-ADM, CDCES

Nurse Practitioner
Centra Health
Lynchburg, Virginia

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Moderator(s)

Deb Bjorsness, MPH, BC-ADM, RD, CDCES

Diabetes Care and Prevention Services Coordinator
Benefis Health System
Great Falls, Montana

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.